🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +9.56% on $DUOL.RTH in just 96h 1m.
EYP
$EYPT
🔒 US EquitiesEyePoint Inc
AVG HISTORICAL GAP
+1.21%
MAX GAP RECORD
+13.71%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $EYPT
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$EYPT
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 05, 2026 Earnings Release 2026-08-05 (UNDETERMINED) |
+0.00%
|
| May 06, 2026 Earnings Release 2026-05-06 (UNDETERMINED) |
+0.00%
|
| Mar 04, 2026 Earnings Release 2026-03-04 (BEFORE OPEN) |
-3.77%
|
| Nov 05, 2025 Earnings Release 2025-11-05 (BEFORE OPEN) |
-8.72%
|
| Aug 06, 2025 Earnings Release 2025-08-06 (BEFORE OPEN) |
-9.83%
|
| May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN) |
+2.08%
|
| Mar 05, 2025 Earnings Release 2025-03-05 (UNDETERMINED) |
+0.00%
|
| Nov 07, 2024 Earnings Release 2024-11-07 (BEFORE OPEN) |
+2.73%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
7.1%
Bullish Gaps (6)
Bearish Gaps (4)
Neutral / Flat (0)
📖 Intelligence Summary
EyePoint, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗